The effect of zinc supplementation on glucose homeostasis: a randomised double-blind placebo-controlled trial.

Authors:
Attia JR; Holliday E; Weaver N; Peel R; Fleming KC and 11 more

Journal:
Acta Diabetol

Publication Year: 2022

DOI:
10.1007/s00592-022-01888-x

PMCID:
PMC9026040

PMID:
35451678

Journal Information

Full Title: Acta Diabetol

Abbreviation: Acta Diabetol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Endocrinology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestAll authors declare that they have no conflict of interest. Ethics ApprovalThe project was approved by the Hunter New England Human Research Ethics Committee (HREC), a lead HREC (approval ID: 2019/ETH01226) and registered with the University of Newcastle’s HREC (approval ID: H-2018-0302). The reported investigations have been carried out in accordance with the Declaration of Helsinki as revised in 2008. Informed consentInformed consent was obtained from all participants. Conflict of interest All authors declare that they have no conflict of interest."

Evidence found in paper:

"Funding Open Access funding enabled and organized by CAUL and its Member Institutions. This work is jointly supported by the New South Wales (NSW) Ministry of Health Translational Research Grant Scheme (TRGS) for the overall funding of the ZIPPeD study (H18/31636) and Hunter New England Local Health District (HNELHD) integrated care funding allocated by the NSW Ministry Of Health. Blackmores Limited provided the zinc and placebo supplements and funds to support mailing costs. The study funders were not involved in the design of the study; the collection, analysis, and interpretation of data; writing the report; and did not impose any restrictions regarding the publication of the report."

Evidence found in paper:

"Trial registration Australian and New Zealand Clinical Trials Registry, ACTRN12618001120268. Registered on 6 July 2018. "

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025